Dogecoin currently holds the 8th position, with XRP ranked 6th and USDC in between among the top cryptocurrencies. However, analysts anticipate a reversal in their positions soon. Dogecoin's value is on the rise while XRP's movement has either stagnated or experienced a decline. Dogecoin has demonstrated resilience, maintaining its surge even during periods of uncertainty in the crypto market.

Since March, Dogecoin has sustained gains, significantly increasing its market cap from around $15 billion at the beginning of 2024 to $28.6 billion currently. In contrast, XRP's market cap hovers around $33.9 billion, leaving a gap of approximately 15.6% to be bridged. If Dogecoin continues its upward trajectory and XRP struggles to overcome bearish resistance, a reversal in their positions seems inevitable.

In terms of token value, Dogecoin has surged by 1.50% in the last 24 hours, trading at $0.1999, while XRP has experienced a decline of 0.85%, with a price of $0.6115. Predictions suggest Dogecoin may reach $12 in the near future, although long-term estimates remain uncertain. The entry of TON and ADA into the market is expected to impact dynamics, although analysts do not foresee a significant effect on the Dogecoin versus XRP trend.

Looking at TON by Toncoin and Cardano's ADA, both have experienced fluctuations in the last 24 hours, with values of $7.06 and $0.5836, respectively. Regarding Dogecoin versus XRP, some predictions suggest Dogecoin could reach as high as $100, although the community consensus currently leans towards $12 as a more practical estimate.

The market cap of Dogecoin continues to rise while XRP's market cap declines, suggesting a potential shift in rankings. Dogecoin's strength lies in its strong community engagement and adoption pace. On the other hand, XRP anticipates a boost in its ETF product following the resolution of the SEC versus Ripple case. The XRP community hopes that ETF approval will significantly increase their holdings' value and the token's market cap, although the actual impact remains to be seen pending regulatory approval.